Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acquisition
Manufacturing
Korea's Celltrion throws down $330M for Lilly plant in N.J.
After teasing its position in a bidding contest for a large U.S. drug substance plant this summer, South Korea’s Celltrion has sealed the deal.
Fraiser Kansteiner
Sep 23, 2025 9:24am
PE firm strikes €4.1B deal for Czech generics maker Zentiva: FT
Sep 11, 2025 10:25am
CorMedix buys Melinta for $300M, adding 7 marketed products
Aug 7, 2025 11:36am
Merck had no other competition in its $10B buyout of Verona
Aug 7, 2025 7:00am
Publicis Health picks up p-value medical comms group
Jul 29, 2025 11:30am
Real Chemistry grows Greater Than One in new acquisition
Jul 22, 2025 8:00am